Dmitry Nikolaevich Sokolov

Title: Dmitry Nikolaevich Sokolov: Innovator in Molecular Biology

Introduction

Dmitry Nikolaevich Sokolov is a notable inventor based in Novosibirskaya oblast, r.p. Koltsovo, Russia. He has made significant contributions to the fields of molecular biology, biochemistry, and biotechnology. His work focuses on developing compounds that exhibit inhibitory effects on specific enzymes, which can have important implications in medical research.

Latest Patents

Sokolov holds a patent for a compound known as 2-acetyl-6-(2-(2-(4-bromobenzylidene)hydrazinyl)thiazole-4-yl)-3,7,9-trihydroxy-8,9b-dimethyldibenzo[b,d]furan-1(9bh)-one. This compound is a hydrazine-thiazole derivative of usnic acid and is designed to inhibit the action of the human tyrosyl-DNA-phosphodiesterase 1 enzyme. The technical result of this invention is an increase in the inhibitory action towards the enzyme Tdp1, as well as an increase in the number of inhibitors of this enzyme. The patent includes 1 independent claim, 2 figures, and 3 examples, showcasing the innovative nature of his work.

Career Highlights

Throughout his career, Sokolov has worked with various organizations, including Innovative Pharmacology Research LLC (iPhar) and the Society with Limited Liability "Innovative Pharmacology Research" (iPhar). His experience in these companies has allowed him to further his research and development in pharmacology and biotechnology.

Collaborations

Sokolov has collaborated with notable colleagues such as Olga Anatolyevna Luzina and Alexandra Leonidovna Zakharenko. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Dmitry Nikolaevich Sokolov is a prominent figure in the field of molecular biology, with a focus on developing innovative compounds that inhibit specific enzymes. His contributions through patents and collaborations highlight his commitment to advancing scientific research and biotechnology.